Substance use disorders and neurologic illness

被引:0
|
作者
Davies R.D. [1 ]
Thurstone C. [1 ]
Woyewodzic K. [1 ]
机构
[1] Department of Psychiatry, Univ. of Colorado Health Sci. Center, Denver, CO 90262
关键词
Cocaine; Traumatic Brain Injury; Amphetamine; Naltrexone; Ecstasy;
D O I
10.1007/s11940-996-0032-8
中图分类号
学科分类号
摘要
Because of the high rates of substance use disorders among the general and clinical populations, and the abuse potential of many medications commonly used in the treatment of neurologic illnesses, the treating neurologist must deal with drug misuse and abuse in practice. The most important tool neurologists must have in their arsenal is the ability to assess for and recognize substance use disorders in their patients. Any treatment plan developed for such patients must include ongoing management of substance abuse issues. After a substance use disorder is diagnosed, the neurologist must make proper referrals to adjunctive support interventions (Alcoholics Anonymous or Narcotics Anonymous) and chemical dependency specialists, and work closely and in collaboration with these components of the patient's overall treatment. The treating neurologist should be aware of the myriad neurologic sequelae of drug use, because most drugs of abuse, including alcohol, can have neurologic manifestations resulting from acute intoxication, acute withdrawal, or chronic use. Drug use (past and present) should be included in the differential diagnosis for any patient with an atypical constellation of symptoms or with isolated neurologic deficits. If the treatment of a neurologic condition requires the use of a potentially addictive substance, particularly when the patient has a history of substance use disorders, then the clinician must minimize the risk of addiction by giving the least addictive substances and developing a plan to manage the use of the drug throughout the treatment period. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:421 / 432
页数:11
相关论文
共 50 条
  • [1] Anxiety disorders in neurologic illness
    Robert D. Davies
    Sherri L. Gabbert
    Paula D. Riggs
    [J]. Current Treatment Options in Neurology, 2001, 3 (4) : 333 - 346
  • [2] Mood disorders in neurologic illness
    Christopher D. Schneck
    Randall D. Buzan
    [J]. Current Treatment Options in Neurology, 2000, 2 (2) : 151 - 168
  • [3] Family support and substance use outcomes for persons with mental illness and substance use disorders
    Clark, RE
    [J]. SCHIZOPHRENIA BULLETIN, 2001, 27 (01) : 93 - 101
  • [4] Medical morbidity, mental illness, and substance use disorders
    Dickey, B
    Normand, SLT
    Weiss, RD
    Drake, RE
    Azeni, H
    [J]. PSYCHIATRIC SERVICES, 2002, 53 (07) : 861 - 867
  • [5] Hope for People with Mental Illness and Substance Use Disorders
    Linda Rosenberg
    [J]. The Journal of Behavioral Health Services & Research, 2010, 37 : 145 - 146
  • [6] Hope for People with Mental Illness and Substance Use Disorders
    Rosenberg, Linda
    [J]. JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2010, 37 (02): : 145 - 146
  • [7] Criminal Recidivism in Inmates with Mental Illness and Substance Use Disorders
    Zgoba, Kristen M.
    Reeves, Rusty
    Tamburello, Anthony
    Debilio, Lisa
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2020, 48 (02): : 209 - 215
  • [8] Substance use disorders among youth with chronic physical illness
    Luther, Alexander W. M.
    Reaume, Shannon, V
    Qadeer, Rana A.
    Thompson, Kara
    Ferro, Mark A.
    [J]. ADDICTIVE BEHAVIORS, 2020, 110
  • [9] SUBSTANCE USE DISORDERS AND MENTAL-ILLNESS - THE RELEVANCE OF COMORBIDITY
    ELGUEBALY, N
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1995, 40 (01): : 2 - 3
  • [10] Quality of care for substance use disorders in patients with serious mental illness
    Kilbourne, AM
    Salloum, I
    Dausey, D
    Cornelius, JR
    Conigliaro, J
    Xu, XY
    Pincus, HA
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2006, 30 (01) : 73 - 77